Legal entity

Novartis

Company NVS

court-decisions is the sole category represented across all 1 tracked stories. Henrietta Lacks is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Each story carries 2 original sources on average, compared with 3.3 for the broader beat in this window.

Last mentioned: Jul 27, 2026

Entity pulse

Recent coverage · Novartis

1 story
5 avg impact
0% positive
0% negative
  • 100% neutral

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

What the coverage shows about Novartis

court-decisions is the sole category represented across all 1 tracked stories. Henrietta Lacks is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Each story carries 2 original sources on average, compared with 3.3 for the broader beat in this window. The 5 average consequence score is below the beat benchmark of 6.4 in the same window. Novartis appears in 1 tracked Legal story from February 27, 2026.

Stories tracked
1
Sources per story
2

Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 47 Legal stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.

Coverage cohort

Appears alongside

Other entities that clear the same relevance threshold in stories also covering Novartis. Shared-story counts are live from our verified record — not editorial picks.

Timeline

  1. Novartis Settlement

    Novartis reaches an agreement to resolve the estate's claims of unjust enrichment.

  2. Thermo Fisher Settlement

    The Lacks estate reaches the first major settlement with a biotech company over HeLa cells.

  3. Death of Henrietta Lacks

    Lacks passes away from cancer, unaware her cells have become the first immortal human cell line.

  4. Cells Harvested

    Henrietta Lacks' cervical cancer cells are harvested at Johns Hopkins without her consent.

Stories mentioning Novartis 1

Court Decisions Neutral

Novartis Settles With Henrietta Lacks Estate Over Unauthorized HeLa Cell Use

Novartis has reached a settlement with the estate of Henrietta Lacks, addressing the decades-long commercial exploitation of her 'immortal' HeLa cells without consent. This agreement marks a significant legal precedent for the biotechnology industry, highlighting the shift toward accountability for biological material provenance in modern medicine.

2 sources

Source: ocregister.com · orlandosentinel.com

Novartis is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.

See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.